Per policy, these medications require cardiac and/or special monitoring. (KEY: "Y" = may be given as described on chart. "N" = may NOT be given except in Rapid Response/Code Blue situations or as otherwise described in Exceptions section of Policy.
generic (Brand) / Notes
CCU, OR, PACU, CCL, ED
PCU
2N (Tele)
1N (Tele), 3N (Tele)
Med/Surg (1N w/o Tele, 3N w/o Tele, 4N, 5N)
BirthPlace
SNF
ICS
OPS
phenytoin (Dilantin) IV Push,IV infusion
Y
Y
Y
Y
N
N
N
N
N
Per policy, these hazardous drugs have special waste requirements.
Generic (Brand)
Waste Requirements
phenytoin (Dilantin)
Injection ⇒ BLACK BUCKET
Medications Requiring Filters
Medication
Preparation Filter
Administration Filter
phenytoin sodium (Dilantin)
Not required.
Use a 0.22 to 0.55 micron inline filter.IMH: For IV infusions, use a 0.22 micron in-line filter.
USP <800> Hazardous Drug Assessment of Risk (AOR)
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances. The following outlines must be followed.
• Transport (dose is placed inside a plastic sealable bag): Standard
Nursing: Storage / Administration
Exposure Risk: moderate
• Handling/administration PPE Requirements: Single CX glove, gown
• Storage of Finished dose in Nursing Area/Procedural Area: Patient Med Drawer
• Signage on Patient Door Required: No
• Manipulation of Dosage Form: n/a
• Special Manipulation for Administration: n/a
Disposal / Spills
• Disposal of Drug Waste: Full- black bin Trace- yellow bin
• Disposol of Used PPE: trash bin (inside plastic bag)
• Spill management: n/a
NIOSH Supplemental Information: IARC Group 1 carcinogen; NTP
Reason for exemption of USP<800> Containment Requirements: Preg Category D. No NIOSH requirements but is highest Group for carcinogen to humans; likely only by systemic absorption. For skin contact, remove contaminated clothing, flush area with large amounts of water and soap. Per MSDS, "possible carcinogen"
(KEY: "Y" = may be given as described on chart. "N" = may NOT be given except in Rapid Response/Code Blue situations or as otherwise described in Exceptions section of Policy.
IV Push,IV infusion
The following outlines must be followed.
[Packaging: Manufacturer ⇒ Dispense]
[n/a]
NIOSH Table 2↑
Receiving / Storage / Preparation
Storage / Administration
Trace- yellow bin